01.26.24 -- A Robust M&A Outlook For 2024

The company’s a bit larger than those we typically cover, and that’s okay! Sometimes, the smartest approach to creating your own masterpiece is to study the masters. On the Business of Biotech, we sit down with Incyte Group Vice President and Head of its Inflammation and AutoImmunity Group Dr. Jim Lee for a dissection of their approach to the comprehensive and efficient R&D that leads to repeated clinical and commercial success.

Process validation is a critical step in the successful commercialization of a new biopharmaceutical. Learn about the challenges and the importance of applying it throughout the entire product life cycle.

Uncover how performance and regulatory expectations differ for regulatory agencies in various markets, influenced by regional drug review trends, approval decisions, and regulatory guidance.

A bad feeling in your gut is a firm starting point, but strategies exist to substantiate a bid’s value based on more than the “sniff test.”

The healthcare industry faces persistent issues in maintaining adherence among patients. Delve into the causes of this pervasive challenge and review solutions for achieving optimal adherence outcomes.